BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 30200944)

  • 1. The cost of Mycobacterium avium complex lung disease in Canada, France, Germany, and the United Kingdom: a nationally representative observational study.
    Goring SM; Wilson JB; Risebrough NR; Gallagher J; Carroll S; Heap KJ; Obradovic M; Loebinger MR; Diel R
    BMC Health Serv Res; 2018 Sep; 18(1):700. PubMed ID: 30200944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs and resource utilization patterns in surgical site infections: a pre-COVID-19 perspective from France, Germany, Spain, and the UK.
    Salmanton-García J; Bruns C; Rutz J; Albertsmeier M; Ankert J; Bernard L; Bataille C; Couvé-Deacon E; Fernández-Ferrer M; Fortún J; Galar A; Grill E; Guimard T; Classen AY; Vehreschild JJ; Stemler J; Naendrup JH; Hampl J; Tallon B; Sprute R; Horcajada JP; Mollar-Maseres J; Muñoz P; Pletz MW; Serracino-Inglott F; Soriano A; Vilz TO; Seifert H; Cornely OA; Mellinghoff SC; Liss BJ; Wingen-Heimann SM;
    J Hosp Infect; 2024 May; 147():123-132. PubMed ID: 38467251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying potentially undiagnosed nontuberculous mycobacterial lung disease among patients with chronic obstructive pulmonary disease: Development of a predictive algorithm using claims data.
    Wang P; Marras TK; Allison PD; Hassan M; Chatterjee A
    J Manag Care Spec Pharm; 2023 Aug; 29(8):927-937. PubMed ID: 37243674
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors predisposing to non-tuberculous mycobacterial lung disease in the patients with respiratory isolates of non-tuberculous mycobacteria.
    Szturmowicz M; Siemion-Szcześniak I; Wyrostkiewicz D; Klatt M; Brzezińska S; Zabost A; Lewandowska A; Filipczak D; Oniszh K; Skoczylas A; Augustynowicz-Kopeć E; Kuś J
    Adv Respir Med; 2018 Dec; ():. PubMed ID: 30594992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental mortality associated with nontuberculous mycobacterial lung disease among US Medicare beneficiaries with chronic obstructive pulmonary disease.
    Wang P; Marras TK; Hassan M; Chatterjee A
    BMC Infect Dis; 2023 Nov; 23(1):749. PubMed ID: 37914999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UK and France form partnership to tackle greatest challenges in cancer.
    Wilkinson E
    Lancet Oncol; 2023 Nov; 24(11):1172. PubMed ID: 37778366
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Lee SH; Kim CK; Shin SY; Ki CS; Jhun BW; Moon SM; Kwon OJ; Koh WJ; Lee NY
    Diagn Microbiol Infect Dis; 2019 Feb; 93(2):107-111. PubMed ID: 30236529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by
    Griffith DE; Eagle G; Thomson R; Aksamit TR; Hasegawa N; Morimoto K; Addrizzo-Harris DJ; O'Donnell AE; Marras TK; Flume PA; Loebinger MR; Morgan L; Codecasa LR; Hill AT; Ruoss SJ; Yim JJ; Ringshausen FC; Field SK; Philley JV; Wallace RJ; van Ingen J; Coulter C; Nezamis J; Winthrop KL;
    Am J Respir Crit Care Med; 2018 Dec; 198(12):1559-1569. PubMed ID: 30216086
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in a Large U.S. Managed Care Health Plan, 2008-2015.
    Winthrop KL; Marras TK; Adjemian J; Zhang H; Wang P; Zhang Q
    Ann Am Thorac Soc; 2020 Feb; 17(2):178-185. PubMed ID: 31830805
    [No Abstract]   [Full Text] [Related]  

  • 10. Horizontal Gene Transfer and Drug Resistance Involving
    Xia X
    Antibiotics (Basel); 2023 Aug; 12(9):. PubMed ID: 37760664
    [No Abstract]   [Full Text] [Related]  

  • 11. Changing Incidence and Characteristics of Nontuberculous Mycobacterial Infections in Scotland and Comparison With
    Jarchow-MacDonald A; Smith M; Seagar AL; Russell CD; Claxton P; Laurenson IF; Moncayo-Nieto OL
    Open Forum Infect Dis; 2023 Jan; 10(1):ofac665. PubMed ID: 36726549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and delivery.
    van der Laan R; Snabilié A; Obradovic M
    Respir Res; 2022 Dec; 23(1):376. PubMed ID: 36566170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settings.
    Aksamit T; Wu J; Hassan M; Achter E; Chatterjee A
    BMC Pulm Med; 2022 Dec; 22(1):461. PubMed ID: 36463137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease.
    Ratnatunga CN; Tungatt K; Proietti C; Halstrom S; Holt MR; Lutzky VP; Price P; Doolan DL; Bell SC; Field MA; Kupz A; Thomson RM; Miles JJ
    Front Immunol; 2022; 13():1047781. PubMed ID: 36439147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual prevalence estimation of lymphatic malformation with a cutaneous component: observational study of a national representative sample of physicians.
    Gallagher JR; Martini J; Carroll S; Small A; Teng J
    Orphanet J Rare Dis; 2022 May; 17(1):192. PubMed ID: 35550604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early IL-17A production helps establish Mycobacterium intracellulare infection in mice.
    Jung BG; Samten B; Dean K; Wallace RJ; Brown-Elliott BA; Tucker T; Idell S; Philley JV; Vankayalapati R
    PLoS Pathog; 2022 Apr; 18(4):e1010454. PubMed ID: 35363832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study.
    Veziris N; Andréjak C; Bouée S; Emery C; Obradovic M; Chiron R
    BMC Infect Dis; 2021 Nov; 21(1):1165. PubMed ID: 34789152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure of
    Danelishvili L; Armstrong E; Miyasako E; Jeffrey B; Bermudez LE
    Antibiotics (Basel); 2020 Dec; 9(12):. PubMed ID: 33352715
    [No Abstract]   [Full Text] [Related]  

  • 19. Short-Chain Fatty Acids Promote
    Silva CAME; Rojony R; Bermudez LE; Danelishvili L
    Pathogens; 2020 Aug; 9(9):. PubMed ID: 32859077
    [No Abstract]   [Full Text] [Related]  

  • 20. Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001-2012.
    Ramsay LC; Shing E; Wang J; Marras TK; Kwong JC; Brode SK; Jamieson FB; Sander B
    Emerg Infect Dis; 2020 Sep; 26(9):2097-2107. PubMed ID: 32818392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.